Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[250 Pages Report] According to Future Market Insight's newly released Surgical Sphincteroplasty Market analysis report, the market valuation stands at US$ 1.5 Bn in 2021 and is expected to rise at a CAGR of 7.4% during the forecasted period of 2022 to 2032. This can be seen as a significant fall from the historic CAGR of 6.1%.
The Global Market is expected to offer an absolute dollar opportunity of US$ 1.6 Bn during the forecasted period. The market is being driven by the increased prevalence of Anal Incontinence (AI), affordable sphincteroplasty procedures and the rising frequency of obstetric injury after childbirth.
Sphincteroplasty is the most common surgery performed for individuals with Anal Incontinence (Moderate to severe level), who have failed to respond to conservative treatment. As per the National Institute of Diabetes and Digestive and Kidney Diseases, Anal incontinence (AI) is a chronic illness affecting around 33% people globally.
Attributes | Details |
---|---|
Surgical Sphincteroplasty Market CAGR (2022 to 2032) | 7,4% |
Surgical Sphincteroplasty Market Size (2022) | US$ 1.6 Billion |
Surgical Sphincteroplasty Market Size (2032) | US$ 3.2 Billion |
Furthermore, research show that AI affects roughly 15% of women in the general population and about 50% of those in nursing homes. The risk of Al is increased by additional factors like Pelvic surgery, age, recurrent diarrhoea, obesity, and other medical disorders such as diabetes and stroke.
Non-Surgical Sphincteroplasty stands to be the prominent segment in the Surgical Sphincteroplasty Market. It is likely to grow rapidly during the forecast period with the CAGR of 7.2%. This growth is significantly higher from the historical CAGR of 6.1%.
This rising percentage is due to the Non-Surgical category's increasing popularity among the elderly and its ability to promptly restore anal sphincter control after delivery. Sacral nerve stimulation, vaginal balloon implants, and other treatments are among the options. Non-surgical treatments have shown encouraging results in patients with end-stage AI and those who have failed to respond to traditional treatment.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the publications released by Future Market Insight - market research and competitive intelligence provider, the Surgical Sphincteroplasty Market is valued at US$ 1.5 Bn in 2021 and is expected to become a US$ 1.6 Bn market by the end of 2022.
The projected CAGR stands at 7.4% for the period between 2022 and 2032, which is significantly higher than the historical CAGR of just 6.1% due to an increase in Anal Incontinence (AI), affordable sphincteroplasty procedures and the rising frequency of obstetric injury after childbirth.
The market is estimated to offer an absolute dollar opportunity of US$ 1.6 Bn in the period between 2022 and 2032 and is likely to record a valuation of US$ 3.2 Bn by 2032.
The key developments in Market are:
In comparison to other therapies for incontinence, sphincteroplasty is a feasible procedure and has become more popular among surgeons. The procedure with low-maintenance and a high success rate is likely to push the adoption rate in healthcare segment.
The rising prevalence of anal incontinence, obstetric damage after childbirth, the increasing innovative approaches for treating AI and the expanding number of clinical studies are all driving the industry forward.
Presented medical conditions ranging from adult in tow to obesity may lead to the increase of the risk of anal incontinence to as high as ninety percent. Thus, increasing the demand for Surgical Sphincteroplasty procedures for treating such medical ailments.
The worldwide economy was severely hit by the COVID-19 pandemic. The COVID-19 pandemic emerged abruptly and prompted the imposition of strict lockdown measures in several countries. Clinical trials in industrialised countries were terminated as a result of pandemic, thus affecting the market growth.
Furthermore, the fear of contacting virus from hospitals visits resulted in fewer elective procedures and lower hospital admission rates. The surgical sphincteroplasty market has been hit by a shortage of surgical supplies as a result of a logistical problems as well as a shortage of hospital care workers. However, it is expected to become competitive by the end of 2022 with patients returning to hospitals with their delayed elective and interventional surgeries.
The United States is the driving force behind the growth of Global Surgical Sphincteroplasty Market. It is expected to remain a dominant market player in the Global Market with the market share of over 35%. The U.S. Market is expected to grow exponentially at a CAGR of 7.2% during the forecasted period, while its historical growth stands at just 6.1%.
Between 2022 and 2032, the market is estimated to offer an absolute dollar opportunity of US$ 568.7 Mn. The region is likely to remain dominant market player due to better healthcare infrastructure and the presence of major industry players. Besides, the market is expected to develop because of an increased R&D expenditure for establishment of concrete treatment choices for anal incontinence.
According to Future Market Insight data, the market in Japan is anticipated to grow at the fastest rate of 11.1% during the period between 2022 and 2032. Its compound annual growth rate is much higher than the historical rate of just 5.3%. In the next ten years, the Japanese market for Surgical Sphincteroplasty is estimated to offer an absolute dollar opportunity of US$ 83.3 million.
The market growth is attributable to the factors such as rising geriatric population, improved adoption rate, greater prevalence of cost-effective operations like sphincteroplasty, improving healthcare infrastructure and higher government investment in the healthcare sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Non-Surgical segment is gaining the utmost traction and was the highest revenue generating segment in the Global Surgical Sphincteroplasty Market. It is expected to grow at a CAGR of 7.2% during the forecasted period. The forecasted growth is significantly higher than the historical growth of just 6.1% during the period between 2017 and 2021.
This is due to its rising popularity among the elderly and its ability to promptly restore anal sphincter control after administration. Sacral nerve stimulation, vaginal balloon implants, and other treatments are included in this category.
Non-surgical treatments have shown encouraging results in patients with end-stage AI and those who have failed to respond to traditional treatment. Due to its high success rate and the ability to reverse or terminate treatment without permanently harming the sacral nerves, sacral nerve stimulation received the most votes.
The leading players in the Surgical Sphincteroplasty Market are increasing their R&D spending to fund the development of strategically advanced offerings. Furthermore, government funding, technological advancements, regulatory approvals, mergers and acquisitions and building a diverse product portfolio have all contributed to the competitive environment's health.
In the market for surgical sphincteroplasty, an increase in clinical advances to produce innovative products is offering attractive opportunities.
It is stated to be a low competitive market because there are fewer market competitors offering surgical solutions to treat anal incontinence. Larger market players, on the other hand, are reported to be boosting market growth through development tactics such as partnership and acquisition.
The key competitors in the Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., Johnson & Johnson, etc.
The recent developments in the Global Surgical Sphincteroplasty Market which were being channelised by market players are as follows:
Similarly, recent developments related to companies offering Surgical Sphincteroplasty have been tracked by the team at Future Market Insight, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historical Data | 2017 to 2021 |
Quantitative Units | In US$ Billion |
Key Regions Covered | North America, Latin America, Europe, APAC and MEA |
Key Countries Covered | United States, China, Japan, South Korea, UK., Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, India, Australia, South Africa, Saudi Arabia, UAE, Israel |
Key Market Segments Covered | Type and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
In 2021, the Global Surgical Sphincteroplasty Devices Market is worth US$ 1.5 Bn and is expected to reach US$ 1.6 Bn by the end of 2022.
The Global Surgical Sphincteroplasty Market is expected to grow at a CAGR of 7.4% during the forecasted period of 2022 to 2032.
The Global Surgical Sphincteroplasty Market is expected to be valued at US$ 3.2 bn by the end of 2032 by growing at a CAGR of 7.4% during next 10 years.
The Global Surgical Sphincteroplasty Market is expected to provide an absolute dollar opportunity of US$ 1.6 Bn during the period 2022 - 2032.
The key players operating in the Global Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., and Johnson & Johnson.
The U.S. dominates the Global Surgical Sphincteroplasty Market with a majority share of over 35% during the current period. The U.S. market is expected to grow at a CAGR of 7.2% during the forecast period, owing to the growing presence of global market players, rising R&D expenditure and favorable regulatory developments in the region.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Investment Feasibility Matrix 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032 5.3.1. Surgical Sphincetroplasty 5.3.2. Non-Surgical Sphincetroplasty 5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 6.1. Introduction 6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 6.3.1. North America 6.3.2. Latin America 6.3.3. Europe 6.3.4. Asia Pacific 6.3.5. Middle East and Africa 6.4. Market Attractiveness Analysis By Region 7. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 7.2.1. By Country 7.2.1.1. U.S. 7.2.1.2. Canada 7.2.2. By Type 7.3. Market Attractiveness Analysis 7.3.1. By Country 7.3.2. By Type 7.4. Key Takeaways 8. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. Brazil 8.2.1.2. Mexico 8.2.1.3. Rest of Latin America 8.2.2. By Type 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.4. Key Takeaways 9. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Germany 9.2.1.2. U.K. 9.2.1.3. France 9.2.1.4. Spain 9.2.1.5. Italy 9.2.1.6. Russia 9.2.1.7. Rest of Europe 9.2.2. By Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.4. Key Takeaways 10. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. China 10.2.1.2. Japan 10.2.1.3. India 10.2.1.4. South Korea 10.2.1.5. Australia 10.2.1.6. Rest of APAC 10.2.2. By Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.4. Key Takeaways 11. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. South Africa 11.2.1.2. Saudi Arabia 11.2.1.3. UAE 11.2.1.4. Israel 11.2.1.5. Rest of MEA 11.2.2. By Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.4. Key Takeaways 12. Key Countries Market Analysis 12.1. U.S. 12.1.1. Pricing Analysis 12.1.2. Market Share Analysis, 2021 12.1.2.1. By Type 12.2. Canada 12.2.1. Pricing Analysis 12.2.2. Market Share Analysis, 2021 12.2.2.1. By Type 12.3. Brazil 12.3.1. Pricing Analysis 12.3.2. Market Share Analysis, 2021 12.3.2.1. By Type 12.4. Mexico 12.4.1. Pricing Analysis 12.4.2. Market Share Analysis, 2021 12.4.2.1. By Type 12.5. Germany 12.5.1. Pricing Analysis 12.5.2. Market Share Analysis, 2021 12.5.2.1. By Type 12.6. U.K. 12.6.1. Pricing Analysis 12.6.2. Market Share Analysis, 2021 12.6.2.1. By Type 12.7. France 12.7.1. Pricing Analysis 12.7.2. Market Share Analysis, 2021 12.7.2.1. By Type 12.8. Spain 12.8.1. Pricing Analysis 12.8.2. Market Share Analysis, 2021 12.8.2.1. By Type 12.9. Italy 12.9.1. Pricing Analysis 12.9.2. Market Share Analysis, 2021 12.9.2.1. By Type 12.10. Russia 12.10.1. Pricing Analysis 12.10.2. Market Share Analysis, 2021 12.10.2.1. By Type 12.11. China 12.11.1. Pricing Analysis 12.11.2. Market Share Analysis, 2021 12.11.2.1. By Type 12.12. Japan 12.12.1. Pricing Analysis 12.12.2. Market Share Analysis, 2021 12.12.2.1. By Type 12.13. India 12.13.1. Pricing Analysis 12.13.2. Market Share Analysis, 2021 12.13.2.1. By Type 12.14. South Korea 12.14.1. Pricing Analysis 12.14.2. Market Share Analysis, 2021 12.14.2.1. By Type 12.15. Australia 12.15.1. Pricing Analysis 12.15.2. Market Share Analysis, 2021 12.15.2.1. By Type 12.16. South Africa 12.16.1. Pricing Analysis 12.16.2. Market Share Analysis, 2021 12.16.2.1. By Type 12.17. Saudi Arabia 12.17.1. Pricing Analysis 12.17.2. Market Share Analysis, 2021 12.17.2.1. By Type 12.18. UAE 12.18.1. Pricing Analysis 12.18.2. Market Share Analysis, 2021 12.18.2.1. By Type 12.19. Israel 12.19.1. Pricing Analysis 12.19.2. Market Share Analysis, 2021 12.19.2.1. By Type 13. Market Structure Analysis 13.1. Competition Dashboard 13.2. Competition Benchmarking 13.3. Market Share Analysis of Top Players 13.3.1. By Regional 13.3.2. By Type 14. Competition Analysis 14.1. Competition Deep Dive 14.1.1. Medtronic 14.1.1.1. Overview 14.1.1.2. Product Portfolio 14.1.1.3. Profitability by Market Segments 14.1.1.4. Sales Footprint 14.1.1.5. Strategy Overview 14.1.1.5.1. Marketing Strategy 14.1.2. Hill-Rom Services, Inc. 14.1.2.1. Overview 14.1.2.2. Product Portfolio 14.1.2.3. Profitability by Market Segments 14.1.2.4. Sales Footprint 14.1.2.5. Strategy Overview 14.1.2.5.1. Marketing Strategy 14.1.3. McKesson 14.1.3.1. Overview 14.1.3.2. Product Portfolio 14.1.3.3. Profitability by Market Segments 14.1.3.4. Sales Footprint 14.1.3.5. Strategy Overview 14.1.3.5.1. Marketing Strategy 14.1.4. B. Braun 14.1.4.1. Overview 14.1.4.2. Product Portfolio 14.1.4.3. Profitability by Market Segments 14.1.4.4. Sales Footprint 14.1.4.5. Strategy Overview 14.1.4.5.1. Marketing Strategy 14.1.5. Becton, Dickinson and Company 14.1.5.1. Overview 14.1.5.2. Product Portfolio 14.1.5.3. Profitability by Market Segments 14.1.5.4. Sales Footprint 14.1.5.5. Strategy Overview 14.1.5.5.1. Marketing Strategy 14.1.6. Novo Surgical, Inc. 14.1.6.1. Overview 14.1.6.2. Product Portfolio 14.1.6.3. Profitability by Market Segments 14.1.6.4. Sales Footprint 14.1.6.5. Strategy Overview 14.1.6.5.1. Marketing Strategy 14.1.7. Surgical Holdings 14.1.7.1. Overview 14.1.7.2. Product Portfolio 14.1.7.3. Profitability by Market Segments 14.1.7.4. Sales Footprint 14.1.7.5. Strategy Overview 14.1.7.5.1. Marketing Strategy 14.1.8. Pelvalon 14.1.8.1. Overview 14.1.8.2. Product Portfolio 14.1.8.3. Profitability by Market Segments 14.1.8.4. Sales Footprint 14.1.8.5. Strategy Overview 14.1.8.5.1. Marketing Strategy 14.1.9. Salix Pharmaceutical Inc. 14.1.9.1. Overview 14.1.9.2. Product Portfolio 14.1.9.3. Profitability by Market Segments 14.1.9.4. Sales Footprint 14.1.9.5. Strategy Overview 14.1.9.5.1. Marketing Strategy 14.1.10. Johnson & Johnson 14.1.10.1. Overview 14.1.10.2. Product Portfolio 14.1.10.3. Profitability by Market Segments 14.1.10.4. Sales Footprint 14.1.10.5. Strategy Overview 14.1.10.5.1. Marketing Strategy 15. Assumptions & Acronyms Used 16. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 02: Global Market Value (US$ Mn) Forecast by Type, 2017-2032 Table 03: North America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 04: North America Market Value (US$ Mn) Forecast by Type, 2017-2032 Table 05: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 06: Latin America Market Value (US$ Mn) Forecast by Type, 2017-2032 Table 07: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 08: Europe Market Value (US$ Mn) Forecast by Type, 2017-2032 Table 09: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 10: Asia Pacific Market Value (US$ Mn) Forecast by Type, 2017-2032 Table 11: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 12: Middle East and Africa Market Value (US$ Mn) Forecast by Type, 2017-2032
Figure 01: Global Market Value (US$ Mn) by Type, 2022-2032 Figure 02: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 03: Global Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 04: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 05: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 06: Global Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 07: Global Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 08: Global Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 09: Global Market Attractiveness by Type, 2022-2032 Figure 10: Global Market Attractiveness by Region, 2022-2032 Figure 11: North America Market Value (US$ Mn) by Type, 2022-2032 Figure 12: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 13: North America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 16: North America Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 17: North America Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 18: North America Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 19: North America Market Attractiveness by Type, 2022-2032 Figure 20: North America Market Attractiveness by Country, 2022-2032 Figure 21: Latin America Market Value (US$ Mn) by Type, 2022-2032 Figure 22: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 23: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 26: Latin America Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 27: Latin America Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 29: Latin America Market Attractiveness by Type, 2022-2032 Figure 30: Latin America Market Attractiveness by Country, 2022-2032 Figure 31: Europe Market Value (US$ Mn) by Type, 2022-2032 Figure 32: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 33: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 36: Europe Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 37: Europe Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 38: Europe Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 39: Europe Market Attractiveness by Type, 2022-2032 Figure 40: Europe Market Attractiveness by Country, 2022-2032 Figure 41: Asia Pacific Market Value (US$ Mn) by Type, 2022-2032 Figure 42: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 43: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 46: Asia Pacific Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 49: Asia Pacific Market Attractiveness by Type, 2022-2032 Figure 50: Asia Pacific Market Attractiveness by Country, 2022-2032 Figure 51: Middle East and Africa Market Value (US$ Mn) by Type, 2022-2032 Figure 52: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032 Figure 53: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis by Type, 2017-2032 Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2022-2032 Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2022-2032 Figure 59: Middle East and Africa Market Attractiveness by Type, 2022-2032 Figure 60: Middle East and Africa Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports